A randomised controlled trial of a moisturiser for treatment of dry skin in atopic dermatitis: effect on the skin barrier in adults with a history of eczema - CSCI-SKT-B1001

ACO Hud Nordic AB0 个研究点目标入组 55 人开始时间: 2023年10月8日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•Participants = 18 years old, A history of atopic dermatitis according to UK working party criteria, Willing and able to provide informed consent

•Substantial flare-up of atopic dermatitis more than minimal (not manageable with moisturiser only) during ideally within the last 6 months, Eczema on the volar forearms, Participants with known or suspected allergies or contraindications to any of the IPs and AxMP ingredients, Participants unwilling to refrain from using prohibited medication including moisturisers (other than the IP, the AxMP and the standard soap for washing), Female participants who, according to the participant, is pregnant or breast-feeding, or plans to become pregnant during the study, Participants judged by the investigator to be inappropriate for the trial., Any serious current medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results or may be contraindicated by the use of the investigational products, Atopic dermatitis targeted systemic therapy as well as any other immunomodulatory systemic therapy over more than 8 days in past 12 months (glucocorticoids, biologicals, cyclosporines, JAK inhibitors, off-label azathioprine, mycophenolate-mofetil, alitretionin, photo therapy), Any treatment with TCS' or other established topical treatment for AD within the last 6 months prior screening and throughout the study. Except the two allowed corticosteroids for treatment of flare-up during the study.

发起方